Integrated treatment of traditional Chinese medicine and western medicine for early-and intermediate-stage diabetic nephropathy
L Zhao, LG Lan, XL Min, AH Lu, LQ Zhu… - Nan Fang yi ke da xue …, 2007 - europepmc.org
Objective To study the therapeutic effect of traditional Chinese herbal medicinal preparation
Tangshenqing (TSQ) combined with alprostadil in the treatment of early-and intermediate …
Tangshenqing (TSQ) combined with alprostadil in the treatment of early-and intermediate …
Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus
Purpose The aim of this study is to prove that type 2 diabetes mellitus can induce increasing
inflammation marker in renal and that the provision of darapladib as Lp-LA2 Inhibitor agents …
inflammation marker in renal and that the provision of darapladib as Lp-LA2 Inhibitor agents …
Role of alpha-lipoic acid in protection from cardiovascular events in patients with hemodialysis
Background: The leading cause of death in patients on hemodialysis (HD) is cardiovascular
events (CVEs). Objective: This study aimed to assess the protective effects of alpha-lipoic …
events (CVEs). Objective: This study aimed to assess the protective effects of alpha-lipoic …
[HTML][HTML] Effects of pentoxifylline on serum markers of diabetic nephropathy in type 2 diabetes
Objective To investigate the effects of pentoxifylline (PTX) in combination with losartan
compared to the high dose of losartan alone on serum markers of diabetic nephropathy such …
compared to the high dose of losartan alone on serum markers of diabetic nephropathy such …
[PDF][PDF] Clinical study of double dose of valsartan combined with tacrolimus in treatment of diabetic nephropathy.
OBJECTIVE: To investigate the clini-cal effect of double dose of valsartan combined with
tacrolimus in the treatment of diabetic nephropathy (DN). PATIENTS AND METHODS: HA …
tacrolimus in the treatment of diabetic nephropathy (DN). PATIENTS AND METHODS: HA …
[HTML][HTML] Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathy
J Ling, YH Yang - World Journal of Diabetes, 2023 - ncbi.nlm.nih.gov
BACKGROUND Early diabetic nephropathy (DN) is a complication of diabetes mellitus. It
mainly affects kidney microvessels and glomerular function, and its timely and effective …
mainly affects kidney microvessels and glomerular function, and its timely and effective …
A prospective single-blind randomized trial of ramipril, eplerenone and their combination in type 2 diabetic nephropathy
M El Mokadem, Y Abd El Hady, A Aziz - Cardiorenal medicine, 2020 - karger.com
Introduction: Angiotensin-converting enzyme inhibitors (ACEI) combined with
mineralocorticoid receptor antagonists were found to have a beneficial effect on patients …
mineralocorticoid receptor antagonists were found to have a beneficial effect on patients …
Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy
L Xie, J Dong, J Wu, C Wei, K Xu, P Lai… - Tropical Journal of …, 2022 - ajol.info
Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and
P38MAPK pathway in diabetic nephropathy (DN) rats. Methods: Sprague Dawley (SD) rats …
P38MAPK pathway in diabetic nephropathy (DN) rats. Methods: Sprague Dawley (SD) rats …
[PDF][PDF] Effects of pravastatin or 12/15 lipoxygenase pathway inhibitors on indices of diabetic nephropathy in an experimental model of diabetic renal disease
HI Gad - Saudi Med. J, 2012 - Citeseer
Objectives: To attenuate the effects of early streptozotocin-induced diabetes on renal
functions through supplementation with either pravastatin or 12/15-lipoxygenase pathway …
functions through supplementation with either pravastatin or 12/15-lipoxygenase pathway …